Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Insulin; related peptides
Patent
1995-02-22
1997-01-14
Nucker, Christine M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Insulin; related peptides
530326, A61K 3828, C07K 7700
Patent
active
055941001
ABSTRACT:
The present invention encompasses peptides derived from the 15 residue peptide 9-23, Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly (SEQ ID NO:1), of the B chain of insulin. Peptides of the present invention are capable of acting as tolerogens for preventing type I diabetes.
REFERENCES:
Llarde, A. et al., "Treatment of non-insulin-dependent diabetes mellitus and its complications", Drugs & Aging 4(6):470-491, 1994. See entire article.
Nucker Christine M.
Pepper Frederick W.
Prickril Benet
Regents of the University of Colorado
LandOfFree
Epitope for prevention of type I diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epitope for prevention of type I diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epitope for prevention of type I diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1389174